AMAG Pharmaceuticals, Inc.

Waltham, Massachusetts 02451

0 studies enrolling now · 5 studies all time

What they study most

Iron Deficiency Anemia, Nondialysis-dependent Chronic Kidney Disease

Studies at this site

• A Phase III Safety Study of Ferumoxytol Compared to Ferric Carboxymaltose for the Treatment of Iron Deficiency Anemia (IDA) — Completed
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Nondialysis-Dependent Chronic Kidney Disease — Stopped early
• A Trial of Ferumoxytol for the Episodic Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease — Stopped early
• A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia — Completed
• A Trial of Ferumoxytol for the Treatment of Iron Deficiency Anemia in Pediatric Participants With Chronic Kidney Disease — Stopped early